Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Organization of cervical cancer screening with DNA–HPV testing impact on early–stage cancer detection: a population–based demonstration study in a Brazilian city. Local targets link to admitted publications; unresolved targets remain external evidence.
Estimate/2020 – Cancer Incidence in Brazil
2020 · External reference
IARC
2005 · External reference
Brazilian Cervical Cancer Screening Guidelines
2016 · External reference
Excessive Pap smears due to opportunistic cervical cancer screening
2008 · External reference
Estimating the public health impact of a national guideline on cervical cancer screening: an audit study of a program in Campinas, Brazil
10.1186/s12889-019-7846-2 · 2019 · External reference
Cervical Cancer Registered in Two Developed Regions from Brazil: Upper Limit of Reachable Results from Opportunistic Screening
10.1055/s-0038-1660841 · 2018 · External reference
Level of human development is associated with cervical cancer stage at diagnosis
10.1080/01443615.2018.1463976 · 2019 · External reference
Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics
10.1136/bmj.318.7188.904 · 1999 · External reference
Impact of the introduction of organised screening for cervical cancer in Turin, Italy: cancer incidence by screening history 1992–98
10.1038/sj.bjc.6602705 · 2005 · External reference
Mass screening programmes and trends in cervical cancer in Finland and the Netherlands
10.1002/ijc.23276 · 2008 · External reference
Efficacy of HPV–basedscreening for prevention of invasive cervical cancer: follow–up of four European randomised controlled trials
10.1016/s0140-6736(13)62218-7 · 2014 · External reference
Cytology versus HPV testing for cervical cancer screening in the general population
2017 · External reference
World Health Organization
2013 · External reference
Human papillomavirus type distribution in invasive cervical cancer and high–grade cervical lesions: A meta–analysis update
10.1002/ijc.22527 · 2007 · External reference
Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population–Based HPV Testing
10.3390/v10120729 · 2018 · External reference
Cervical cancer screening program based on primary DNA–HPV testing in a Brazilian city: a cost–effectiveness study protocol
10.1186/s12889-020-08688-4 · 2020 · External reference
Is the HPV test more cost–effective than cytology in cervical cancer screening? An economic analysis from a middle–income country
10.1371/journal.pone.0251688 · 2021 · External reference
Seade Foundation
2011 · External reference
Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first–line screening test
10.1016/j.ygyno.2014.11.076 · 2015 · External reference
Efficacy of HPV–basedscreening for prevention of invasive cervical cancer: follow–up of four European randomised controlled trials
10.1016/s0140-6736(13)62218-7 · 2014 · External reference
Revised FIGO staging for carcinoma of the cervix uteri
10.1002/ijgo.12749 · 2019 · External reference
City Hall of Indaiatuba
2019 · External reference
Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors
10.1016/j.ejca.2013.04.024 · 2013 · External reference
Status of implementation and organization of cancer screening in the European Union Member States – summary results from the second European screening report
10.1002/ijc.31043 · 2018 · External reference
Effective screening programmes for cervical cancer in low– and middle–income developing countries
2001 · External reference
Cervical cancer in Central and South America: Burden of disease and status of disease control
10.1016/j.canep.2016.07.015 · 2016 · External reference
Disparities in time trends of cervical cancer mortality rates in Brazil
2016 · External reference
Cervical screening: ESGO–EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)
10.1038/s41416-020-0920-9 · 2020 · External reference
Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy Demonstration Project in Argentina: a population–based, before–and–after retrospective cohort study
10.1016/s2214-109x(19)30048-8 · 2019 · External reference
Analysis of conservative surgical treatment and prognosis of microinvasive squamous cell carcinoma of the cervix stage IA1. Results of follow-up to 20 years
10.1097/igc.0000000000000887 · 2017 · External reference